Literature DB >> 6137224

Conversion of 2-beta-D-ribofuranosylselenazole-4-carboxamide to an analogue of NAD with potent IMP dehydrogenase-inhibitory properties.

H N Jayaram, G S Ahluwalia, R L Dion, G Gebeyehu, V E Marquez, J A Kelley, R K Robins, D A Cooney, D G Johns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6137224     DOI： 10.1016/0006-2952(83)90038-2

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

1.  Synergistic antiviral effects of ribavirin and the C-nucleoside analogs tiazofurin and selenazofurin against togaviruses, bunyaviruses, and arenaviruses.

Authors:  J W Huggins; R K Robins; P G Canonico
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

2.  Broad-spectrum synergistic antiviral activity of selenazofurin and ribavirin.

Authors:  J J Kirsi; P A McKernan; N J Burns; J A North; B K Murray; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

3.  Effects of selenazofurin and ribavirin and their 5'-triphosphates on replicative functions of influenza A and B viruses.

Authors:  S K Wray; R H Smith; B E Gilbert; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

Review 4.  What microRNAs could tell us about the human X chromosome.

Authors:  Armando Di Palo; Chiara Siniscalchi; Mariacarolina Salerno; Aniello Russo; Claus Højbjerg Gravholt; Nicoletta Potenza
Journal:  Cell Mol Life Sci       Date:  2020-04-30       Impact factor: 9.261
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.